697 related articles for article (PubMed ID: 12020338)
1. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
3. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
[TBL] [Abstract][Full Text] [Related]
4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
5. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
[TBL] [Abstract][Full Text] [Related]
7. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
[TBL] [Abstract][Full Text] [Related]
8. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
Nordwall M; Hyllienmark L; Ludvigsson J
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
[TBL] [Abstract][Full Text] [Related]
9. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
[TBL] [Abstract][Full Text] [Related]
10. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
Genuth S
Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
[TBL] [Abstract][Full Text] [Related]
11. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
[TBL] [Abstract][Full Text] [Related]
12. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
[TBL] [Abstract][Full Text] [Related]
13. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
McCarter RJ; Hempe JM; Gomez R; Chalew SA
Diabetes Care; 2004 Jun; 27(6):1259-64. PubMed ID: 15161772
[TBL] [Abstract][Full Text] [Related]
14. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
16. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
[TBL] [Abstract][Full Text] [Related]
17. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.
Olsen BS; Sjølie A; Hougaard P; Johannesen J; Borch-Johnsen K; Marinelli K; Thorsteinsson B; Pramming S; Mortensen HB
J Diabetes Complications; 2000; 14(6):295-300. PubMed ID: 11120452
[TBL] [Abstract][Full Text] [Related]
18. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
; Lachin JM; Genuth S; Cleary P; Davis MD; Nathan DM
N Engl J Med; 2000 Feb; 342(6):381-9. PubMed ID: 10666428
[TBL] [Abstract][Full Text] [Related]
19. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
[TBL] [Abstract][Full Text] [Related]
20. [Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus].
Fröhlich-Reiterer EE; Borkenstein MH
Wien Med Wochenschr; 2010 Aug; 160(15-16):414-8. PubMed ID: 20812053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
